Zhejiang Int'l Group Co (000411.SZ) Stock Price

Zhejiang Int'l Group Co Price

CLOSED
9.95
​
Market closed

Over the last 19 years Zhejiang Int'l Group Co grew revenue by 14.1% annually, reaching 33.68 B CNY. Earnings per share have grown at 19.5% per year over the last 19 years. For Zhejiang Int'l Group Co, the net margin of 1.5% is broadly stable versus 0.6% a few years ago. At today's price the dividend yield works out to roughly 3.85%. The payout ratio is around 41% of earnings. The dividend has grown at 23.4% per year over the past 6 years.

Zhejiang Int'l Group Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zhejiang Int'l Group Co business model & stock analysis

Zhejiang Int'l Group Co., Ltd. engages in the wholesale and retail business of pharmaceutical and medical device. The company is headquartered in Hangzhou, Zhejiang and currently employs 2,781 full-time employees. The firm purchases products from pharmaceutical manufacturers or suppliers, then wholesales them to distributors, medical institutions and pharmacies, or sells them directly to consumers through retail terminals. The firm conducts its businesses in Mainland China.

Frequently asked questions about Zhejiang Int'l Group Co

5 analysts currently rate the Zhejiang Int'l Group Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Zhejiang Int'l Group Co share trades at 1.32 EUR (9.95 CNY).

The revenue cannot currently be calculated for Zhejiang Int'l Group Co.

The profit cannot currently be calculated for Zhejiang Int'l Group Co.

The P/E ratio cannot be calculated for Zhejiang Int'l Group Co at the moment.

The P/S cannot be calculated for Zhejiang Int'l Group Co currently.

The Eulerpool Quality Score for Zhejiang Int'l Group Co is 6/10.

The ISIN of Zhejiang Int'l Group Co is CNE0000008D9. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Zhejiang Int'l Group Co is 000411.SZ. The ticker symbol is used to trade Zhejiang Int'l Group Co shares on the stock exchange.

Fair ValueTerminal
9.25 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
12.11 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website intmedic.com
Country
Currency
CNY
Initial public offering
Jul 16, 1996
ISIN
CNE0000008D9
Cusip
Y3042W106
Market capitalization
5.45 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
3.75
P/B Ratio
1.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.38 %
Dividend
Dividend yield
3.85 %
Payout Ratio
40.66 %
Dividend growth Ø5Y
47.87 %
Dividend payments per year
1
Dividend paid since
7 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
10.00 %
Last updated Oct 16, 2026, 12:41 PM

Zhejiang Int'l Group Co Peer Group

Zhejiang Int'l Group Co FIGI

000411:CH · BBG000P69L93000411:CS · BBG000P69MR1000411:C2 · BBG01KJ86H02

All fundamentals and in-depth analysis of Zhejiang Int'l Group Co

Our stock analysis for Zhejiang Int'l Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zhejiang Int'l Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.